Attached files
| file | filename |
|---|---|
| 10-K - 10-K - T2 Biosystems, Inc. | ttoo-20161231x10k.htm |
| EX-32.1 - EX-32.1 - T2 Biosystems, Inc. | ttoo-20161231ex32178a0fd.htm |
| EX-31.2 - EX-31.2 - T2 Biosystems, Inc. | ttoo-20161231ex31202ab9e.htm |
| EX-31.1 - EX-31.1 - T2 Biosystems, Inc. | ttoo-20161231ex3113054df.htm |
| EX-21.1 - EX-21.1 - T2 Biosystems, Inc. | ttoo-20161231ex211412f24.htm |
| EX-10.34 - EX-10.34 - T2 Biosystems, Inc. | ttoo-20161231ex10346516f.htm |
| EX-10.33 - EX-10.33 - T2 Biosystems, Inc. | ttoo-20161231ex103396194.htm |
| EX-10.32 - EX-10.32 - T2 Biosystems, Inc. | ttoo-20161231ex103210bb3.htm |
| EX-10.31 - EX-10.31 - T2 Biosystems, Inc. | ttoo-20161231ex1031cf917.htm |
| EX-10.30 - EX-10.30 - T2 Biosystems, Inc. | ttoo-20161231ex1030dd292.htm |
| EX-10.29 - EX-10.29 - T2 Biosystems, Inc. | ttoo-20161231ex1029648b6.htm |
| EX-10.28 - EX-10.28 - T2 Biosystems, Inc. | ttoo-20161231ex10282c167.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements (Form S-3 No. 333-206707 and Form S-8 Nos. 333-197946) of T2 Biosystems, Inc. and in the related Prospectus of our report dated March 15, 2017, with respect to the consolidated financial statements of T2 Biosystems, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2016.
|
|
/s/ Ernst & Young LLP |
Boston, Massachusetts
March 15, 2017